You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NTRK3

Showing 1 - 25 of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NTRK Family Gene Mutation Trial in Germany

Recruiting
  • NTRK Family Gene Mutation
    • Berlin, Germany
    • +22 more
    Jan 18, 2023

    Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

    Recruiting
    • Thyroid Cancer
    • NTRK fusion assessment
    • Roma, Italy
      Regina Elena National Cancer Institute
    Mar 31, 2023

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Providence (TY-2136b)

    Not yet recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Providence, Rhode Island
      Rhode Island Hospital, Brown University
    Mar 2, 2023

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)

    Completed
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Orange, California
    • +9 more
    Jun 7, 2021

    Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (TPX-0005, Metformin Hydrochloride, Digoxin)

    Recruiting
    • Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Canton, Ohio
      Gabrail Cancer Research Center
    Apr 25, 2023

    Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer Trial in France (Blood and tumor samples)

    Recruiting
    • Soft Tissue Sarcoma
    • +2 more
    • Blood and tumor samples
    • Clermont-Ferrand, France
    • +9 more
    Dec 8, 2021

    High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)

    Recruiting
    • High Grade Glioma
    • Diffuse Intrinsic Pontine Glioma
    • Aurora, Colorado
    • +17 more
    Aug 10, 2022

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Larotrectinib (Vitrakvi, BAY2757556))

    Recruiting
    • Solid Tumors Harboring NTRK Fusion
    • Larotrectinib (Vitrakvi, BAY2757556)
    • Los Angeles, California
    • +50 more
    Jan 29, 2023

    Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • +3 more
    • Oral repotrectinib (TPX-0005)
    • Los Angeles, California
    • +27 more
    Aug 9, 2022

    Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

    Recruiting
    • Cancer
    • +15 more
    • Data collection and quality of life questionnaire
    • Graz, Austria
    • +40 more
    Jul 27, 2021

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (BAY2757556 (Larotrectinib, Vitrakvi))

    Recruiting
    • Solid Tumors Harboring NTRK Fusion
    • BAY2757556 (Larotrectinib, Vitrakvi)
    • Palo Alto, California
    • +158 more
    Aug 8, 2022

    ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

    Terminated
    Has Results
    • ALK Fusion Protein Expression
    • +14 more
    • San Francisco, California
      University of California, San Francisco
    Jan 14, 2020

    Solid Tumors Harboring NTRK Fusion Trial in Worldwide (Selitrectinib (BAY2731954))

    Active, not recruiting
    • Solid Tumors Harboring NTRK Fusion
    • Selitrectinib (BAY2731954)
    • La Jolla, California
    • +28 more
    Aug 18, 2022

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Oral repotrectinib (TPX-0005)
    • Yuma, Arizona
    • +175 more
    Jan 25, 2023

    Solid Tumors Harboring NTRK Fusion Trial (Selitrectinib (BAY2731954))

    No longer available
    • Solid Tumors Harboring NTRK Fusion
    • Selitrectinib (BAY2731954)
    • (no location specified)
    Sep 8, 2021

    Solid Tumor Trial (TL118 Capsule)

    Not yet recruiting
    • Solid Tumor
    • TL118 Capsule
    • (no location specified)
    Aug 18, 2023

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    A Retro-/Prospective, Non-interventional, Cohort Study in Adult

    Active, not recruiting
    • Solid Tumor, Adult
    • +2 more
      • Amiens, France
      • +3 more
      Jul 22, 2022

      Solid Tumors Harboring NTRK Fusion Trial in United States (Larotrectinib (Vitrakvi, BAY2757556))

      Completed
      • Solid Tumors Harboring NTRK Fusion
      • Larotrectinib (Vitrakvi, BAY2757556)
      • Aurora, Colorado
      • +7 more
      May 11, 2021

      NSCLC, Solid Tumor Trial in Boston (Merestinib)

      Active, not recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Solid Tumor
      • Boston, Massachusetts
      • +1 more
      Jan 26, 2022

      Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

      Recruiting
      • Solid Tumors
      • CNS Tumors
      • Orange, California
      • +38 more
      Aug 24, 2022

      Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

      Recruiting
      • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
      • +2 more
      • Beijing, Beijing, China
      • +1 more
      Nov 21, 2023

      Thyroid Carcinoma

      Recruiting
      • Differentiated Thyroid Carcinoma
      • Medullary Thyroid Carcinoma
      • Immunohistochemistry (IHC)
      • +2 more
      • L'Hospitalet De Llobregat, Barcelona, Spain
      • +11 more
      Mar 22, 2022

      Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

      Recruiting
      • Breast Cancer
      • +15 more
      • Goodyear, Arizona
      • +146 more
      Aug 24, 2022

      Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)

      Recruiting
      • Locally Advanced Malignant Solid Neoplasm
      • Metastatic Malignant Solid Neoplasm
      • Larotrectinib Sulfate
      • Houston, Texas
        M D Anderson Cancer Center
      Apr 18, 2022